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Abstract
Background: The catalog of genetic variants in the horse genome originates from a few select animals, the
majority originating from the Thoroughbred mare used for the equine genome sequencing project. The purpose
of this study was to identify genetic variants, including single nucleotide polymorphisms (SNPs), insertion/deletion
polymorphisms (INDELs), and copy number variants (CNVs) in the genome of an individual Quarter Horse mare
sequenced by next-generation sequencing.
Results: Using massively parallel paired-end sequencing, we generated 59.6 Gb of DNA sequence from a Quarter
Horse mare resulting in an average of 24.7X sequence coverage. Reads were mapped to approximately 97% of the
reference Thoroughbred genome. Unmapped reads were de novo assembled resulting in 19.1 Mb of new genomic
sequence in the horse. Using a stringent filtering method, we identified 3.1 million SNPs, 193 thousand INDELs, and
282 CNVs. Genetic variants were annotated to determine their impact on gene structure and function. Additionally,
we genotyped this Quarter Horse for mutations of known diseases and for variants associated with particular traits.
Functional clustering analysis of genetic variants revealed that most of the genetic variation in the horse’s genome
was enriched in sensory perception, signal transduction, and immunity and defense pathways.
Conclusions: This is the first sequencing of a horse genome by next-generation sequencing and the first genomic
sequence of an individual Quarter Horse mare. We have increased the catalog of genetic variants for use in equine
genomics by the addition of novel SNPs, INDELs, and CNVs. The genetic variants described here will be a useful
resource for future studies of genetic variation regulating performance traits and diseases in equids.
Background
The sequencing and assembly of a horse genome was a
great achievement in equine genomics and veterinary
medicine because of the broad range of potential applica-
tions of this information for improving health and perfor-
mance and for understanding differences among species
[1]. To date, however, only a single genome of a Thor-
oughbred mare has been sequenced and made publicly
available [1]. The current catalog of genetic variants in
the equine genome consists of 1,163,580 single nucleo-
tide polymorphisms (SNPs; dbSNP: http://www.ncbi.nlm.
nih.gov/projects/SNP/ [build 135]), with no insertion/
deletion polymorphisms (INDELs) or copy number var-
iants (CNVs) having been deposited into a publicly avail-
able database (dbSNP or dbVar, http://www.ncbi.nlm.nih.
gov/dbvar). Of the known SNPs in horses, most (~64%)
originate from the Thoroughbred mare used for the gen-
ome assembly [1].
Sequencing the genome of a Quarter Horse was consid-
ered important for several reasons. Almost 3 million
Quarter Horses were registered in the United States in
2010 according to the American Quarter Horse Associa-
tion, making it the single largest breed registry in the
country [2,3]. When one includes non-registered Quarter
Horses and other Quarter Horse-influenced breed regis-
tries (e.g., American Paint Horse Association), the Quarter
Horse is by far the largest contributor to the population of
horses in the United States. Although Quarter Horse
breeding was, and continues to be, strongly influenced by
Thoroughbred bloodlines, the 2 breeds were selectively
bred to enhance different traits. Thoroughbred breeding
has selected for speed over distances of 3/4 to 2 miles,
whereas selection in the Quarter Horse has emphasized
speed over shorter distances and compliant disposition
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suited to working cattle and other ranch-related duties [4].
Thus, there are important phenotypic differences between
the breeds that have been achieved by selective breeding
with a clear underlying genetic component [5,6]. More-
over, there are single-gene disorders in Quarter Horses,
such as polysaccharide storage myopathy (PSSM) [7,8],
hyperkalemic periodic paralysis (HYPP) [9], glycogen
branching enzyme deficiency (GBED) [10], and hereditary
equine regional dermal asthenia (HERDA) [11,12]. Most
diseases and traits (such as predisposition to osteoarthritis
or body-type) are complex, involving multiple genes,
which may be modulated by environmental factors
[5,13,14]. Thus, identifying genetic variants in the genome
of a single Quarter Horse would provide a wealth of infor-
mation for future genomic studies in equids.
Here we describe the whole-genome sequencing of an
individual Quarter Horse mare using massively parallel
paired-end sequencing. Sequence reads were mapped to
the reference Thoroughbred nuclear and mitochondrial
genomes. We developed a comprehensive list of genetic
variants, including SNPs, INDELs, and CNVs. We anno-
tated genetic variants and examined their impact on gene
structure and function. The genomic sequence was also
examined for mutations and polymorphisms associated
with diseases and traits in horses. Furthermore, we exam-
ined biological processes enriched for genetic variants
and compared these biological processes between this
Quarter Horse mare and the reference Thoroughbred
mare.
Results
Whole-genome sequencing, alignment, and identification
of new genomic sequence
Genomic DNA was obtained from a single blood sample
of a Quarter Horse mare owned by Texas A&M Univer-
sity. The mare’s pedigree was heavily influenced by
stock and racing Quarter Horses, with no introgression
of Thoroughbred lines during the preceding 4 genera-
tions. A small insert library with an average size of
approximately 270 base-pair (bp) was generated (Addi-
tional file 1, Figure S1), and 14 lanes of 75-bp paired-
end sequencing were performed using the Illumina Gen-
ome Analyzer II (Additional file 2, Table S1) (Illumina,
Inc., San Diego, CA). A schematic of the sequence map-
ping and variant identification, annotation, and analysis
is presented in Figure 1. The sequencing reactions
yielded 849,600,742 reads totaling 61,310,282,925 bases
of DNA (Additional file 3, Table S2). Sequence reads
were trimmed and mapped to the assembled autosomes,
× chromosome, and mitochondrial genome of the refer-
ence Thoroughbred horse genome (EquCab2.0). A total
of 817,470,439 reads (59,643,456,282 bases) were aligned
to approximately 97% of the reference genome
(53,783,377,648 bases were uniquely mapped), resulting
in an average of 24.7X sequence coverage of the horse’s
genome (Additional file 3, Table S2). Sequence coverage
of assembled chromosomes ranged from 13X to 55X
(Additional file 4, Figure S2). Additionally, 81,993 reads
mapped to 100% of the reference mitochondrial gen-
ome, resulting in an average of 355.6X sequence cover-
age. Reads not mapping to assembled chromosomes
were subsequently mapped to the unassembled chromo-
somes (ChrUn), where 12,865,623 reads (935,090,584
bases) were mapped. Next, we de novo assembled
12,657,236 reads (707,253,380 bases) not mapping to the
assembled or unassembled chromosomes. The de novo
assembly yielded 35,540 contigs totaling 19.1 million
bases (Mb) of sequence (Table 1). BLAT and BLAST
analysis of the contigs to other genomes did not result
in any significant alignment.
Identification of genetic variants
We analyzed sequences mapped to the assembled chro-
mosomes for putative SNPs, INDELs, and CNVs. SNPs
were required to meet several stringent criteria (see Mate-
rials and Methods) and were further filtered to remove
those near other variants (i.e., SNPs and INDELs) or
within the pseudo-autosomal region (PAR) of the × chro-
mosome. The resulting SNPs were then filtered using dif-
ferent minimum read-depths (5X and 10X [Additional file
5, Table S3 and Additional file 6, Table S4]). As expected,
increasing the minimum read-depth resulted in fewer
SNPs being detected (1,131,519 SNPs lost from 5X to 10X
coverage; Additional file 7, Table S5 and Additional file 8,
Figure S3A and B). Additionally, we found that a greater
proportion of the total SNPs was lost than that of the total
non-synonymous SNPs, with homozygous SNPs being lost
at the highest rate (Additional file 8, Figure S3C and D).
At 10X coverage, which was the minimum read-depth
used for the subsequent annotation and downstream ana-
lysis, we identified 3,157,093 SNPs. Additionally, we char-
acterized and annotated SNPs detected at lower minimum
read-depths (Additional files 9, 10, 11, 12, 13, 14, 15, 16,
17, 18, 19, 20, 21, 22, and 23, Tables S6, S7, S8, S9, S10,
S11, S12, S13, S14, S15, S16, S17, S18, S19, and S20).
Intergenic SNPs, located within 1,000 bases (1 kb)
upstream or downstream of a gene, were determined as
well as genic SNPs located within introns, non-coding
exons, 5’ and 3’ untranslated regions (UTR), intron and
exon splice sites, and coding exons. Non-synonymous
SNPs were further annotated as either radical or conserva-
tive (Table 2, and Additional files 9, 10, 11, 12, 13, 14, 15,
16, 17, 18, 19, 20, 21, 22, and 23, Tables S6, S7, S8, S9,
S10, S11, S12, S13, S14, S15, S16, S17, S18, S19, and
S20; see Materials and Methods for description of amino
acid classification). Additionally, we identified SNPs
located within the coding exons of 305 candidate
imprinted genes for future studies in the horse ([15];
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Additional file 24, Table S21). Analysis of the mitochon-
drial genome identified 71 SNPs, including 5 heteroplas-
mic SNPs (Additional file 5, Table S3 and Additional
file 6, Table S4).
Comparison of putative SNPs in the mapped sequences
to the horse SNP database (dbSNP, http://www.ncbi.
nlm.nih.gov/projects/SNP/) revealed that 342,726 were
known and 2,814,367 were novel, including 18,140 non-
synonymous SNPs (11,434 radical and 6,706 conserva-
tive) and 2,629 complex (i.e., tri-allelic) SNPs. Compari-
son of the putative SNPs to those identified in the
sequencing and assembly of the reference Thoroughbred
Figure 1 Overview of genome-wide variation analysis pipeline by next generation sequencing.
Table 1 Sequence generation and mapping to equCab2 reference genome
Method Lanes Reads Bases
Mapped (Gb)
Average Depth of
Coverage
% of Reference
Mapped
Bases Mapped to
ChrUn (Mb)
De Novo Assembly of
Unmapped (Mb)
75 PE 14 817,470,439 59.6 24.7 X 97% 935.1 19.1
Doan et al. BMC Genomics 2012, 13:78
http://www.biomedcentral.com/1471-2164/13/78
Page 3 of 11
genome revealed that 244,669 SNPs were overlapping
between the 2 horses, including 174,682 intergenic and
69,987 genic SNPs. By removing overlapping known
SNPs, we found that the Quarter Horse and Thor-
oughbred genomes had 2,912,424 and 522,610 unique
SNPs, respectively.
Using a minimum read-depth of 10X and similar filter-
ing methods described for the SNP analysis, we identified
193,271 INDELs (1-8 bp insertion or deletions; Table 3
and Additional file 25, Table S22). Additionally, we iden-
tified and annotated INDELs using lower read-depth cov-
erage (5X; Additional file 26, Table S23). Although our
analysis was limited to INDELs no greater than 8 bp, the
overwhelming majority were single bp gains and losses
(Additional file 27, Figure S4). Of the INDELs identified,
2,574 caused a frameshift mutation (frameshift deletion +
insertions) in a coding exon, whereas 35 did not (Table 3).
In addition, 21 INDELs lead to the creation of a stop
codon (stop - gain). Given the high number of INDELs
affecting coding exons, particularly the large number of
homozygous INDELs, we annotated them using the
RefSeq annotation. The analysis revealed that 50 RefSeq
genes contained INDELs, including 7 genes with loss of a
stop codon and 47 with a frameshift.
Copy number variants (CNVs) were identified using a
read-depth algorithm that corrects for GC bias. CNVs
were then filtered to remove those within telomeric
regions, as investigation of these regions is associated
with high false discovery rates [16]. The filtered analysis
revealed 282 CNVs, including 274 gains, 6 losses, and 2
homozygous deletions (Additional file 28, Table S24,
Additional file 29, Figure S5 and Additional file 30,
Figure S6). The sizes ranged from 3.74 kb to 4.84 Mb,
with an average length of 296.1 kb. Annotation of the
CNVs indicated that 192 and 90 were genic and inter-
genic, respectively.
Pathway, trait, and disease analysis of identified genetic
variants
We performed a functional annotation clustering analy-
sis of genes containing SNPs, INDELs, and CNVs to
Table 2 Annotation of SNPs in the Quarter Horse genome
Total Homozygous Heterozygous Novel Ensembl Genes
All SNPs 3,157,093 1,293,374 1,863,719 2,814,367 24,023
Intergenic 2,224,292 908,169 1,316,123 1,991,041 19,644
Intergenic (Upstream w/in 1 kb) 40,948 19,241 21,707 37,566 12,803
Intergenic (Downstream w/in 1 kb) 31,901 13,327 18,574 28,494 10,580
Intergenic (Up/Down w/in 1 kb) 929 427 502 866 399
Genic 859,023 352,210 506,813 756,400 19,414
Intron 811,204 332,455 478,749 712,764 14,778
Non-Coding Exon 5,935 2,019 3,916 5,575 2,123
5’ UTR 1,734 1,014 720 1,630 1,049
3’ UTR 1,821 780 1,041 1,594 1,184
Intron Splice Site 300 185 115 280 276
Exon Splice Site 657 320 337 593 595
Coding Exon 37,372 15,437 21,935 33,964 10,485 (305 imprinted)
Synonymous 19,667 7,626 12,041 17,699 7,982
Stop Gain 214 50 164 206 190
Stop Loss 8 5 3 7 8
Non-Synonymous 18,140 8,076 10,064 16,645 6,899
Table 3 Annotation of INDELs in the Quarter Horse
genome
INDEL Location Total Homozygous Heterozygous
INDELs (1 bp - 8 bp) 193,271 127,173 66,098
Intergenic 122,571 78,538 44,033
Intergenic (Upstream w/in 1
kb)
5,900 5,073 827
Intergenic (Downstream w/
in 1 kb)
2,557 1,853 704
Intergenic (Up/Down w/in 1
kb)
126 105 21
Genic 62,117 41,604 20,513
Intron 57,618 37,377 20,241
Non-Coding Exon 277 239 38
5’ UTR 594 557 37
3’ UTR 249 195 54
Intron Splice Site 749 735 14
Exon Splice Site 771 762 9
Coding Exon 1,859 1,739 120
Frameshift Deletion 1,594 1,533 61
Frameshift Insertion 980 940 40
Non-Frameshift Deletion 23 4 19
Non-Frameshift Insertion 12 5 7
Stop - Gain 21 19 2
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identify biological processes (BP) enriched for these
classes of genetic variants. Using the horse Ensembl
gene identification (ID) for the functional annotation
clustering, we found that only a small percentage of BP
terms were returned (0.6%). Therefore, we decided to
perform the analysis using the human orthologs of
horse genes found to possess genetic variants. Of the
6,899 genes containing non-synonymous SNPs, 5,712
had human orthologs and 3,880 returned BP terms
(67.9%). Clustering analysis indicated that non-synon-
ymous SNPs were enriched (P < 0.05) in pathways for
sensory perception (27%; P = 3.9 × 10-15), cellular pro-
cesses (24%; P = 1.7 × 10-6), and signal transduction
(16% P = 2.7 × 10-7; Figure 2A and Additional file 31,
Table S25). Separate functional enrichment analysis of
genes with either radical or conservative non-synon-
ymous SNPs revealed that the biological processes of
the enriched pathways remained unchanged, although
there was an increase in enrichment of conservative
amino acid changes in the immunity and defense path-
way (3% radical and 14% conservative; Additional file 32,
Figure S7A and B). Clustering analysis of INDELs indi-
cated that genes containing variants were enriched in
pathways for signal transduction (26%; P = 4.2 × 10-6),
developmental processes (15%; P = 3.5 × 10-10), and cel-
lular processes (14%; P = 1.4 × 10-5; Figure 2B). Analysis
of CNVs indicated that genes containing variants were
enriched in pathways for sensory perception (60%; P =
2.1 × 10-61), immunity and defense (19%; P = 2.7 × 10-2),
and signal transduction (13%; P = 1.3 × 10-3; Figure 2C).
Comparison of biological pathways containing hetero-
zygous non-synonymous SNPs between the Quarter
Horse and reference Thoroughbred (Additional file 33,
Table S26) revealed that the Quarter Horse had SNPs
enriched in pathways for sensory perception (36%; P =
1.3 × 10-36), cellular processes (18%; P = 4.8 × 10-5), and
signal transduction (16%; P = 1.2 × 10-3; Additional file
34, Figure S8A), whereas the Thoroughbred had SNPs
enriched in pathways for immunity and defense (36%;
P = 5.2 × 10-8), sensory perception (23%; P = 6.4 × 10-14),
and cellular processes (13%; P = 2.7 × 10-1; Additional
file 34, Figure S8B). As the enrichment analysis reflected
percentages of genes within pathways, and because the
Quarter Horse contained nearly three times as many het-
erozygous SNPs as the Thoroughbred, we determined
the total number of genes for each BP term that con-
tained a non-synonymous heterozygous SNP. As
expected, the Quarter Horse had more genes containing
SNPs for each BP class, except for the immune and
defense (P = 2.4 × 10-27) and nucleic acid metabolism
(P = 1.1 × 10-11) pathways (Additional file 34, Figure
S8C, Additional file 35, Tables S27 and Additional
file 36, Table S28).
Next, we investigated the DNA sequence of the Quar-
ter Horse mare for mutations of known diseases and for
SNPs associated with various traits in horses (Table 4).
We found the Quarter Horse to be heterozygous for a
c.115G > A mutation in the cyclophilin B (PPIB) gene,
which causes hereditary equine regional dermal asthenia
(HERDA)[12], heterozygous for the g.901C > T SNP
associated with chestnut coat color [17], and homozy-
gous for the g.66493737C > T and g.22684390C > T
SNPs associated with racing endurance in Thor-
oughbred horses [18,19]. No other mutations or poly-
morphisms underlying known diseases or traits were
identified.
Discussion
The current catalog of equine genetic variants is limited
and primarily consists of those detected from the sequen-
cing and assembly of a single Thoroughbred horse [1]. In
the present study, we describe the whole-genome
sequencing and identification of genetic variants in the
genome of a Quarter Horse mare. To our knowledge,
this is the first published report of a whole-genome
sequence of a Quarter Horse and the only horse genome
sequenced by next-generation sequencing. At 25X
sequence coverage, we estimated that approximately
85-88% of the horse’s genome could be genotyped [20].
Our analysis yielded 3.1 million SNPs, 193 thousand
INDELs, and 282 CNVs. Despite the fact that approxi-
mately 10% of the novel homozygous SNPs likely reflect
errors in the reference genome (given that the accuracy
of the reference genome is 99.99%) and that our false dis-
covery rate (FDR) for SNP detection is approximately
1.5% (Doan et al. unpublished studies), the genetic var-
iants identified here represent a significant addition to
what is currently available for studies in horses. It should
be noted that the breeding structure of Quarter Horses
and Thoroughbreds, as well as the differences in sequen-
cing technology (i.e., next-generation sequencing of DNA
fragments vs. Sanger sequencing of bacterial artificial
clones) most likely contributed to the increased amount
of genetic variation identified in this study. We suspect
that many genetic variants were missed due to the para-
meters applied during our variant detection (e.g., requir-
ing a minimum of 10X sequence coverage). To minimize
this false negative rate (FNR) we provide a list of SNPs
and INDELs using a less stringent calling criterion
(5X minimum sequence coverage; Additional file 5,
Table S3). However, caution should be used with these
variants as the FDR is expected to increase with a
reduced minimum coverage, although not directly pro-
portional to the decrease of the FNR.
De novo assembly of reads not mapping to the
assembled or un-assembled chromosomes led to the
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generation of 19.1 Mb of new horse genomic sequence.
Our analysis of CNVs in horses and cattle using array
comparative genomic hybridization (Doan et al., unpub-
lished studies), as well as studies in the human and
mouse show that large (Mb) deletions are common var-
iants in the genome [21-24]. This presence/absence var-
iation [25] is common, and thus we suspect that some
percentage of the de novo assembled sequence repre-
sents sequence missing from the reference Thor-
oughbred genome due to homozygous deletions.
Functional annotation clustering analysis of genetic
variants revealed that pathways for sensory perception,
signal transduction, protein processing, cellular process,
and immunity and defense were differentially affected by
each type of genetic variant (i.e., SNPs, INDELs, and
CNVs), suggesting varying degrees of tolerance and
selection for genetic variants underlying these biological
processes. Genes involved in sensory perception path-
ways contained most of the genetic variation, primarily
SNPs (27%) and CNVs (60%). The observed enrichment
Figure 2 Biological process enrichment analysis of identified genetic variants. (A) BP enrichment analysis of non-synonymous coding SNPs,
(B) INDELs, and (C) CNVs.
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in sensory perception genes may be related to selection
of the Quarter Horse for a relatively calm disposition
[26,27], although this is highly speculative at this point,
and will only be determined by future population based-
studies. Conversely, these variants could reflect misas-
semblies in the reference genome or misalignments in
the Quarter Horse reads to the reference sequence, as
these genes exist as large families with numerous
pseudogenes.
Conclusions
This is the first sequencing of a horse genome by next-
generation sequencing and the first genomic sequence
of an individual Quarter Horse. The genetic variants
Table 4 Analysis of genetic variants for known traits and diseases
PMID Chromosome Coordinate Gene Gene Name Phenotype Associated
Genotype
QH
Genotype
20353955
[32]
1 108,249,293 TRPM1 transient receptor potential
cation channel
Leopard complex spotting and
congenital stationary night blindness
C/C C/T T/T
17498917
[12]
1 128,056,148 PPIB peptidyl-prolyl cis-trans
isomerase B
Hereditary equine regional dermal
asthenia
A/A G/A
20419149
[33]
1 138,235,715 MYO5A myosin-Va isoform 1 Lavender foal syndrome Del 1 bp Neg
8995760
[34]
3 36,259,552 MC1R melanocyte-stimulating
hormone receptor
Chestnut coat color T/T C/T
11086549
[17]
3 36,259,554 MC1R melanocyte-stimulating
hormone receptor
Chestnut coat color A/A G/G
16284805
[35]
3 77,735,520 KIT mast/stem cell growth
factor receptor
Sabino spotting A/A A/T T/T
18253033
[36]
3 77,740,163 KIT mast/stem cell growth
factor receptor
Tobiano spotting pattern A/A A/G G/G
21070277
[6]
4 38,969,307 PDK4 pyruvate dehydrogenase
kinase isozyme 4
Racing performance A/A A/C C/C
21070277
[6]
4 38,973,231 PDK4 pyruvate dehydrogenase
kinase isozyme 4
Racing performance A/A A/G G/G
12230513
[37]
5 20,256,789 LAMC2 laminin subunit gamma-2
precursor
Junctional epidermolysis bullosa Ins C Neg
17029645
[38]
6 73,665,304 PMEL17 melanocyte protein 17
precursor
Silver coat color T/T T/C C/C
19016681
[39]
8 45,603,643-
45,610,231
LAMA3 laminin alpha-3 Junctional epidermolysis bullosa Del 6,589 Neg
9103416
[40]
9 35,528,429 DNAPK DNA-dependent protein
kinase catalytic subunit
Severe combined immunodeficiency Del 5 bp Neg
15318347
[41]
10 9,554,699 RYR1 ryanodine receptor 1
isoform 2
Malignant hyperthermia G/G G/C C/C
21059062
[19]
10 15,884,567 CKM creatine kinase M-type Racing performance A/A A/G G/G
18358695
[7]
10 18,940,324 GYS1 glycogen [starch] synthase
muscle
Polysaccharide storage myopathy A/A A/G G/G
7623088
[42]
11 15,500,439 SCN4A sodium channel protein
type 4 subunit alpha
Equine hyperkalemic periodic paralysis G/G G/C C/C
18802473
[43]
14 26,701,092 SLC36A1 proton-coupled amino acid
transporter 1
Champagne dilution C/C C/G G/G
9580670
[44]
17 50,624,658 EDNRB endothelin B receptor
precursor
Lethal white foal syndrome AG/AG TC/TC
20932346
[18]
18 66,493,737 MSTN growth/differentiation factor
8 precursor
Optimum racing distance T/T T/T
12605854
[45]
21 30,666,626 SLC45A2 membrane-associated
transporter protein isoform
Cream coat color A/A A/G G/G
21059062
[19]
22 22,684,390 COX4I2 cytochrome c oxidase
subunit 4 isoform 2
Racing performance T/T T/C T/T
11353392
[46]
22 25,168,567 ASIP agouti-signaling protein
precursor
Black and bay color Del 11 bp ND
18641652
[47]
25 6,574,013-
6,581,600
STX17 syntaxin 17 Gray coat color Dup 4,600 Neg
Abbreviations: Del, Deletion; Ins, Insertion; Neg, Negative; ND, Not Determined; Dup, Duplication
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identified in this study will be a useful resource for
future studies to understand the genetic basis of pheno-
typic variation and disease in equids.
Methods
DNA sample
DNA was isolated from whole blood of a Quarter Horse
mare using a standard phenol-chloroform extraction
including 2 phenol-chloroform-isoamyl (PCI) steps, fol-
lowed by rinses with chloroform, isopropanol, and 70%
ethanol. The sample was suspended in Qiagen EB buffer
(Qiagen Sciences, Germantown, MD). The Texas A&M
University Institutional Animal Care and Use Commit-
tee approved this study.
Whole-genome sequencing
For the construction of sequencing libraries, we first soni-
cated high-quality genomic DNA by pulsing 3X for 15
sec/pulse at 14% using a Sonic Dismembrator 500 (Fisher
Scientific, Pittsburg, PA) and purified with an Invitrogen
PureLink PCR Kit (Invitrogen, Carlsbad, CA). The DNA
was blunt end-repaired, adenylated, and ligated with
paired-end adaptors, according to the manufacturer’s pro-
tocol (Illumina, San Diego CA). The prepared library was
resolved on a 2% low range agarose gel and a 2-mm sec-
tion of DNA was isolated at 271 bp (Qiagen Sciences, Ger-
mantown, MD). The library was then enriched according
to the manufacturer’s protocol (Illumina, San Diego CA).
The size and concentration of the sequencing library was
determined by PCR, visualization of polyacrylamide gel
electrophoresis (PAGE) gels, and through the use of the
Agilent 2100 Bioanalyzer DNA kit (Agilent Technologies,
San Diego CA). Cluster generation and paired-end
sequencing was performed according to the manufac-
turer’s protocols (Illumina) at the AgriLife Genomics and
Bioinformatics Center (College Station, TX)
Sequence alignment
We used the trim function in the CLC Genomics Work-
bench (CLC Bio, Aarhus, Denmark) using the following
parameters: ambiguous limit, 2; ambiguous trim, yes; qual-
ity limit, 0.1; quality trim, yes; and, remove 3’ nucleotide,
no; remove 5’ nucleotide, no. The CLC Genomics Work-
bench Reference Mapping function was used to assemble
the trimmed reads to the equCab2 reference assembly
using the following parameters: similarity score = 0.8; and,
length fraction = 0.5. Paired-end reads were mapped using
an insert range of 180-bp to 500-bp and reads mapping to
multiple places in the reference were mapped using the
random setting. In order to determine the percent of the
genome that was mapped by uniquely mapped read, we
used the previously stated settings with nonspecific reads
being ignored.
SNP detection
We used the SNP detection function in CLC Genomics
Workbench, based on the neighborhood quality standard
(NQS) algorithm, using the following parameters: mini-
mum coverage = 5; minimum central base quality = 30;
average base quality over a window length of 11 nucleo-
tides = 15; and, minimum allele frequency = 35%. SNPs
were filtered by removing those within 10 bp of another
variant (both INDELs and SNPs). Also, SNPs located
within the pseudo-autosomal region (PAR) were removed
[28]. The remaining SNPs were filtered by read-depth to
create SNP analyses with minimum depths of 5, 6, 7, 8, 9,
and 10.
INDEL detection
We used the deletion and insertion polymorphism (DIP)
function in CLC Genomics Workbench using the fol-
lowing parameters: minimum coverage = 5; minimum
allele frequency = 35%; and, maximum expected varia-
tions = 2. INDELs were filtered in a similar manner as
SNPs, with those near other variants and within the
PAR being removed. Analyses were conducted at both
5X and 10X read-depths.
CNV detection
We used the Control-FREE copy number algorithm
(FREEC) program to identify CNVs in the mapped
sequence data [16]. We optimized the program for our
data using a break-point threshold of -0.0013 and a
coefficient of variation of 0.045. Additionally, we
removed any CNVs located within 1 Mb of the begin-
ning and end of all chromosomes in order to reduce the
potential for erroneous calling.
Genetic variant annotation and analysis
We re-annotated the variant calls from CLC Genomics
using both Galaxy http://galaxy.psu.edu/ and ANNOVAR
software programs [29,30]. The join and merge functions
in Galaxy were used to annotate the SNPs and INDELs.
We used these functions to compare the SNPs to all
known SNPs in dbSNP as well as those identified in the
reference horse. The ANNOVAR program used the
Ensembl annotation database to create an mRNA library,
allowing for the determination of amino acid changes. The
program was used to determine the locations of all var-
iants within the genome. We also annotated the known
SNPs from the reference Thoroughbred genome to deter-
mine amino acid changes as well as gene locations for a
comparison to the Quarter Horse. The SNPs were divided
into groups based on radical and conservative amino acid
changes, where radical SNPs result in a difference in polar-
ity or charge when the amino acid was changed while con-
servative SNPs cause no change in polarity or charge.
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The gene lists for each group were converted to
human Ensembl gene IDs using Ensembl Biomart. Bio-
logical function analysis was performed through the
DAVID Functional Annotation Tool, using the default
settings [31]. The resulting biological process terms
were further grouped by similarities in function to
determine enrichment for specific biological processes
(Additional file 37, Table S29). Statistical significance
(p-value) for each enriched group was determined using
Fisher’s combined probability test with the p-value cre-
ated from the DAVID Functional Annotation Tool. The
enriched genes for each biological process group were
compared between the Quarter Horse and reference
Thoroughbred using the Fisher’s exact test for a 2 × 2
contingency table.
Analysis of de novo assembly of unmapped reads
We created a de novo assembly of all reads that did not
align to the reference genome (including ChrMt and
ChrUn) using de Bruijn Graphs (CLC Genomics). We
were able to assemble 8,186,040 of the 12,657,236
unmapped reads into contigs with minimum and aver-
age contig lengths of 200 bp and 537 bp, respectively.
We performed de novo assembly of reads not mapping
to either assembled or unassembled chromosomes using
the following parameters: similarity = 0.8; length fraction
= 0.5; insertion cost = 3; deletion cost = 3; mismatch
cost = 3; minimum paired distance = 180 bp; and, maxi-
mum paired distance = 500 bp. The resulting 35,540
contigs were further analyzed by BLAST, mapping all
complete genomes and chromosomes from RefSeq.
Sequence data and genetic variants
The Illumina FASTQ data generated from this study has
been submitted to the NCBI Sequence Read Archive
http://www.ncbi.nlm.nih.gov/sra under accession num-
ber SRX110702. The mapped sequences and genetic var-
iants have been submitted to Intrepid Bioinformatics
and are available for public viewing http://server1.intre-
pidbio.com/FeatureBrowser/ngsdatasetrecord/record?
ngsrecord=6197673305. A complete list of SNPs,
INDELs, and CNVs are listed in Additional files 5, 6,
and 24, Tables S3, S4 and S24.
Additional material
Additional file 1: Distribution of paired-end sequencing library
insert length. Figure indicating distribution of library insert length and
number of sequence reads generated per length.
Additional file 2: Sequencing reaction statistics. Table of raw
summary statistics of each lane of Illumina sequencing.
Additional file 3: Detailed overview of mapping results. Table of
total sequence reads (paired and single end), the number of mapped
reads and bp to assembled and unassembled chromosomes.
Additional file 4: Average depth of coverage of assembled
chromosomes. Figure of average mapping read coverage of each
chromosome.
Additional file 5: 5X filtered SNPs and INDELS identified by whole
genome sequencing. Table listing chromosomal coordinates of SNPs
and INDELs identified using a minimum sequence read depth coverage
of 5X.
Additional file 6: 10X filtered SNPs and INDELS identified by whole
genome sequencing. Table listing chromosomal coordinates of SNPs
and INDELs identified using a minimum sequence read depth coverage
of 10X.
Additional file 7: Loss of SNPs by post-filtering. Table describing the
number of SNPs and INDELs removed by post-filtering.
Additional file 8: Comparison of minimum depth of coverage SNP
filters. Total number of (A) SNPs and (B) non-synonymous SNP
remaining after increasing the minimum sequence read depth of
coverage. Proportion of homozygous and heterozygous (C) SNPs and (D)
non-synonymous SNPs lost by increasing minimum sequence read depth
of coverage.
Additional file 9: Annotation of SNPs with minimum read depth
coverage of 5X. Table describing the genic annotation of SNPs
identified at 5X coverage.
Additional file 10: Annotation of SNPs with minimum read depth
coverage of 5X relative to the Ensembl gene annotation. Table
describing the intergenic and genic location of SNPs identified at 5X
coverage.
Additional file 11: Genes affected by SNPs with minimum read
depth coverage of 5X. Table describing the number of genes identified
with SNPs, including the annotation of the SNPs within the genetic
elements.
Additional file 12: Overview of SNP annotation with minimum read
depth coverage of 5X. Table summarizing the number and annotation
of SNPs with minimum read depth coverage of 5X.
Additional file 13: Annotation of SNPs with minimum read depth
coverage of 6X. Table describing the genic annotation of SNPs
identified with minimum read depth coverage of 6X coverage.
Additional file 14: Annotation of SNPs with minimum read depth
coverage of 6X relative to the Ensembl gene annotation. Table
describing the intergenic and genic location of SNPs identified with
minimum read depth coverage of 6X coverage.
Additional file 15: Annotation of SNPs with minimum read depth
coverage of 7X. Table describing the genic annotation of SNPs
identified with minimum read depth coverage of 7X coverage.
Additional file 16: Annotation of SNPs with minimum read depth
coverage of 7X relative to the Ensembl gene annotation. Table
describing the intergenic and genic location of SNPs identified with
minimum read depth coverage of 7X coverage.
Additional file 17: Annotation of SNPs with minimum read depth
coverage of 8X. Table describing the genic annotation of SNPs
identified with minimum read depth coverage of 8X coverage.
Additional file 18: Annotation of SNPs with minimum read depth
coverage of 8X relative to the Ensembl gene annotation. Table
describing the intergenic and genic location of SNPs identified with
minimum read depth coverage of 8X coverage.
Additional file 19: Annotation of SNPs with minimum read depth
coverage of 9X. Table describing the genic annotation of SNPs
identified with minimum read depth coverage of 9X coverage.
Additional file 20: Annotation of SNPs with minimum read depth
coverage of 9X relative to the Ensembl gene annotation. Table
describing the intergenic and genic location of SNPs identified with
minimum read depth coverage of 9X coverage.
Additional file 21: Annotation of SNPs with minimum read depth
coverage of 10X. Table describing the genic annotation of SNPs
identified with minimum read depth coverage of 10X coverage.
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Additional file 22: Annotation of SNPs with minimum read depth
coverage of 10X relative to the Ensembl gene annotation. Table
describing the intergenic and genic location of SNPs identified with
minimum read depth coverage of 10X coverage.
Additional file 23: Genes affected by SNPs with minimum read
depth coverage of 10X. Table describing the number of genes
identified with SNPs, including the annotation of the SNPs within the
genetic elements.
Additional file 24: Imprinted genes containing SNPs in coding
regions. List of known imprinted genes in humans containing coding
SNPs in Quarter Horse.
Additional file 25: Annotation of INDELs with minimum read depth
coverage of 5X.
Additional file 26: Annotation of INDELs with minimum read depth
coverage of 10X. Table describing genic annotation and location of
INDELs with minimum read depth coverage of 10X.
Additional file 27: Distribution of total number of INDELs by length.
Plot showing the number of INDELS by length identified with minimum
read depth coverage of 10X.
Additional file 28: Coordinates of CNVs. Table describing the location
of CNVs identified by analysis of read depth.
Additional file 29: Identification of a loss within an olfactory gene
cluster by sequencing read-depth. Plot of read depth indicating a
copy number loss within olfactory gene cluster.
Additional file 30: Identification of a homozygous deletion by read-
depth coverage. Plot of read depth indicating a homozygous deletion.
Additional file 31: Biological process enrichments and associated p-
values for SNPs, INDELS, and CNVs with minimum read depth
coverage of 10X. Statistical analyses of biological process enrichments
for SNP, INDELS, and CNVs with minimum read depth coverage of 10X.
Additional file 32: Biological process enrichment analysis of
conserved and radical non-synonymous SNPs. Statistical analyses of
biological process enrichments for conserved and radical SNPs with
minimum read depth coverage of 10X.
Additional file 33: Annotation of SNPs in the reference
Thoroughbred genome. Table describing genic annotation and location
of known SNPs in the reference Thoroughbred genome.
Additional file 34: Comparison of biological processes affected by
SNPs in the Quarter Horse and Thoroughbred genomes. (A) BP
enrichment of non-synonymous homozygous SNPs and (B) heterozygous
SNPs in the Quarter Horse genome. (C) BP enrichment of non-
synonymous heterozygous SNPs in the Thoroughbred genome. (D)
Number of genes containing non-synonymous SNPs within each BP
pathway.
Additional file 35: Biological process enrichments and associated p-
values for SNP comparison between Quarter Horse and reference
Thoroughbred with minimum coverage of 10 reads. Comparison and
statistical analysis of biological process enrichments between Quarter
Horse and reference Thoroughbred.
Additional file 36: Statistical analysis of enriched genes in the
Quarter Horse and reference Thoroughbred. Statistical analysis of
comparison between enriched genes in the Quarter Horse and reference
Thoroughbred.
Additional file 37: Biological process terms and classification. All
terms used for biological processes enrichment and their associated
category.
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